CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands		3 Months Ended		6 Months Ended
		Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023		Jun. 30, 2022
Revenues:
Premiums earned, net (Net of ceded premiums of $113 and $119, for the three months ended June 30, 2023 and 2022, respectively; net of ceded premiums of $235 and $238 for the six months ended June 30, 2023 and 2022, respectively)		$ 314,383	$ 268,505	$ 631,469		$ 546,674
Non-Insurance revenue		193,490	577,370	399,273		1,172,268
Other income		5,755	825	10,661		2,137
Total revenues		513,628	846,700	1,041,403		1,721,079
Operating expenses:
Net medical claims incurred		436,954	858,786	909,444		1,720,508
Salaries and benefits		62,437	70,491	132,644		139,582
General and administrative expenses		42,433	47,040	99,841		104,737
Premium deficiency reserve benefit		(5,138)	(27,476)	(6,948)		(54,952)
Depreciation and amortization		999	586	1,278		1,412
Restructuring costs		4,750	0	6,557		0
Total operating expenses		542,435	949,427	1,142,816		1,911,287
Loss from operations		(28,807)	(102,727)	(101,413)		(190,208)
Interest expense		7	390	7		793
Amortization of notes and securities discounts		0	18	0		18
Loss (gain) on investment		0	1,227	0		(11,167)
Net loss		$ (28,814)	$ (104,362)	$ (101,420)		$ (179,852)
Per share data:
Net loss per share attributable to Class A and Class B common stockholders - basic (in dollars per share)		$ (0.06)	$ (0.22)	$ (0.21)	[1]	$ (0.38)	[1]
Net loss per share attributable to Class A and Class B common stockholders - diluted (in dollars per share)		$ (0.06)	$ (0.22)	$ (0.21)	[1]	$ (0.38)	[1]
Weighted average number of common shares outstanding
Weighted Average Number of Shares Outstanding, Basic	[1]	479,163,752	476,061,809	479,819,237		474,553,609
Diluted weighted average number of Class A and Class B common shares and common share equivalents outstanding (in shares)	[1]	479,163,752	476,061,809	479,819,237		474,553,609
Net unrealized gain (loss) on available-for-sale investments		$ 316	$ (1,095)	$ 2,659		$ (6,419)
Comprehensive loss		$ (28,498)	$ (105,457)	$ (98,761)		$ (186,271)

[1] (1) Because the Company had a net loss during the six months ended June 30, 2023 and 2022, the Company's potentially dilutive securities, which include stock options, restricted stock, preferred stock, and warrants to purchase shares of common stock and preferred stock, have been excluded from the computation of diluted net loss per share, as the effect would be anti-dilutive.